Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -3,353 | -2,308 | -1,160 | -3,464 |
| Depreciation Amortization | 55 | 37 | 18 | 206 |
| Accounts payable and accrued liabilities | 273 | 262 | 200 | N/A |
| Other Working Capital | 284 | 373 | 339 | 159 |
| Other Operating Activity | -157 | -198 | -163 | 215 |
| Operating Cash Flow | $-2,898 | $-1,834 | $-766 | $-2,884 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2 | -2 | -2 | 0 |
| Investing Cash Flow | $-2 | $-2 | $-2 | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 61 | 61 | N/A | N/A |
| Debt Repayment | -58 | -47 | -29 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 6,092 |
| Financing Cash Flow | $3 | $14 | $-29 | $6,092 |
| Beginning Cash Position | 3,821 | 3,821 | 3,821 | 613 |
| End Cash Position | 924 | 1,999 | 3,024 | 3,821 |
| Net Cash Flow | $-2,897 | $-1,822 | $-797 | $3,208 |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,898 | -1,834 | -766 | -2,884 |
| Capital Expenditure | -2 | -2 | -2 | N/A |
| Free Cash Flow | -2,900 | -1,836 | -768 | -2,884 |